Global and China Hereditary Cancer Testing Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Hereditary Cancer Testing industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Laboratory Corporation of America

    • Myogenes

    • Biocartis

    • Myriad Genetics

    • Quest Diagnostics

    • Pathway Genomics

    • Strand Life Sciences

    • Invitae Corporation

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Biopsy

    • Imaging

    • Others

    Application:

    • Hospital

    • Clinics

    • Diagnostic Centers

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Hereditary Cancer Testing Industry Overview

      • 1.1.1 Hereditary Cancer Testing Market Scope and Market Segments

      • 1.1.2 Hereditary Cancer Testing Industry Characteristics

      • 1.1.3 Global and China Hereditary Cancer Testing Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Hereditary Cancer Testing Production Value and Growth Rate (2017-2028)

    • 1.2 Global Hereditary Cancer Testing Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Biopsy

      • 1.2.2 Imaging

      • 1.2.3 Others

    • 1.3 Global Hereditary Cancer Testing Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital

      • 1.3.2 Clinics

      • 1.3.3 Diagnostic Centers

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Hereditary Cancer Testing Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Hereditary Cancer Testing Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Hereditary Cancer Testing Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Hereditary Cancer Testing Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Hereditary Cancer Testing Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Hereditary Cancer Testing Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Hereditary Cancer Testing Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Hereditary Cancer Testing Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Hereditary Cancer Testing Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Hereditary Cancer Testing Industry Porter's Five Forces Model Analysis

      • 2.2.3 Hereditary Cancer Testing Industry PEST Analysis

    • 2.3 Hereditary Cancer Testing Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Hereditary Cancer Testing Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Hereditary Cancer Testing Industry

    Chapter 3 Global and China Hereditary Cancer Testing Market, by Manufacturer

    • 3.1 Global and China Hereditary Cancer Testing Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Hereditary Cancer Testing Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Hereditary Cancer Testing Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Hereditary Cancer Testing Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Hereditary Cancer Testing Market Top 3 Players

    Chapter 4 Global and China Hereditary Cancer Testing Market, by Type (2017-2028)

    • 4.1 Hereditary Cancer Testing Market Trend, by Type

    • 4.2 Global Hereditary Cancer Testing Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Hereditary Cancer Testing Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Hereditary Cancer Testing Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Hereditary Cancer Testing Price Trend, by Type (2017-2028)

    • 4.3 China Hereditary Cancer Testing Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Hereditary Cancer Testing Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Hereditary Cancer Testing Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Hereditary Cancer Testing Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Hereditary Cancer Testing Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Hereditary Cancer Testing Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Hereditary Cancer Testing Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Hereditary Cancer Testing Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Hereditary Cancer Testing Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Hereditary Cancer Testing Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Hereditary Cancer Testing Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Hereditary Cancer Testing Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Hereditary Cancer Testing Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Hereditary Cancer Testing Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Hereditary Cancer Testing Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Hereditary Cancer Testing Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Hereditary Cancer Testing Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Hereditary Cancer Testing Market Analysis

    • 7.1 North America Hereditary Cancer Testing Market, by Type

    • 7.2 North America Hereditary Cancer Testing Market, by Application

    • 7.3 North America Hereditary Cancer Testing Market Analysis and Forecast, by Country

      • 7.3.1 United States Hereditary Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Hereditary Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Hereditary Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Hereditary Cancer Testing Market Analysis

    • 8.1 Europe Hereditary Cancer Testing Market, by Type

    • 8.2 Europe Hereditary Cancer Testing Market, by Application

    • 8.3 Europe Hereditary Cancer Testing Market Analysis and Forecast, by Country

      • 8.3.1 Germany Hereditary Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Hereditary Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Hereditary Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Hereditary Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Hereditary Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Hereditary Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Hereditary Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Hereditary Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Hereditary Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Hereditary Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Hereditary Cancer Testing Market Analysis

    • 9.1 APAC Hereditary Cancer Testing Market, by Type

    • 9.2 APAC Hereditary Cancer Testing Market, by Application

    • 9.3 APAC Hereditary Cancer Testing Market Analysis and Forecast, by Country

      • 9.3.1 China Hereditary Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Hereditary Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Hereditary Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Hereditary Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Hereditary Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Hereditary Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Hereditary Cancer Testing Market Analysis

    • 10.1 Latin America, Middle East and Africa Hereditary Cancer Testing Market, by Type

    • 10.2 Latin America, Middle East and Africa Hereditary Cancer Testing Market, by Application

    • 10.3 Latin America, Middle East and Africa Hereditary Cancer Testing Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Hereditary Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Hereditary Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Hereditary Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Hereditary Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Hereditary Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Hereditary Cancer Testing Company Profiles

      • 11.1 Laboratory Corporation of America

        • 11.1.1 Laboratory Corporation of America Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Laboratory Corporation of America Hereditary Cancer Testing Product Profiles, Application and Specification

        • 11.1.3 Laboratory Corporation of America Hereditary Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Myogenes

        • 11.2.1 Myogenes Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Myogenes Hereditary Cancer Testing Product Profiles, Application and Specification

        • 11.2.3 Myogenes Hereditary Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Biocartis

        • 11.3.1 Biocartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Biocartis Hereditary Cancer Testing Product Profiles, Application and Specification

        • 11.3.3 Biocartis Hereditary Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Myriad Genetics

        • 11.4.1 Myriad Genetics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Myriad Genetics Hereditary Cancer Testing Product Profiles, Application and Specification

        • 11.4.3 Myriad Genetics Hereditary Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Quest Diagnostics

        • 11.5.1 Quest Diagnostics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Quest Diagnostics Hereditary Cancer Testing Product Profiles, Application and Specification

        • 11.5.3 Quest Diagnostics Hereditary Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Pathway Genomics

        • 11.6.1 Pathway Genomics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Pathway Genomics Hereditary Cancer Testing Product Profiles, Application and Specification

        • 11.6.3 Pathway Genomics Hereditary Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Strand Life Sciences

        • 11.7.1 Strand Life Sciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Strand Life Sciences Hereditary Cancer Testing Product Profiles, Application and Specification

        • 11.7.3 Strand Life Sciences Hereditary Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Invitae Corporation

        • 11.8.1 Invitae Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Invitae Corporation Hereditary Cancer Testing Product Profiles, Application and Specification

        • 11.8.3 Invitae Corporation Hereditary Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Hereditary Cancer Testing Industry Investment Prospect and Risk Assessment

    • 12.1 Hereditary Cancer Testing Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Hereditary Cancer Testing Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Hereditary Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure China Hereditary Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Global Hereditary Cancer Testing Production Value and Growth Rate (2017-2028)

    • Figure China Hereditary Cancer Testing Production Value and Growth Rate (2017-2028)

    • Figure Global Hereditary Cancer Testing Market Size and Growth Rate of Biopsy (2017-2028)

    • Figure Global Hereditary Cancer Testing Market Size and Growth Rate of Imaging (2017-2028)

    • Figure Global Hereditary Cancer Testing Market Size and Growth Rate of Others (2017-2028)

    • Figure Global Hereditary Cancer Testing Market Size and Growth Rate of Hospital (2017-2028)

    • Figure Global Hereditary Cancer Testing Market Size and Growth Rate of Clinics (2017-2028)

    • Figure Global Hereditary Cancer Testing Market Size and Growth Rate of Diagnostic Centers (2017-2028)

    • Figure North America Hereditary Cancer Testing Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Hereditary Cancer Testing Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Hereditary Cancer Testing Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Hereditary Cancer Testing Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Hereditary Cancer Testing Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Hereditary Cancer Testing Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Hereditary Cancer Testing Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Hereditary Cancer Testing Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Hereditary Cancer Testing Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Hereditary Cancer Testing Market Share, by Manufacturer in 2021

    • Figure Global and China Hereditary Cancer Testing Market Share, by Manufacturer in 2022

    • Table Global Hereditary Cancer Testing Sales Volume, by Type (2017-2028)

    • Table Global Hereditary Cancer Testing Sales Volume Share, by Type (2017-2028)

    • Figure Global Hereditary Cancer Testing Sales Volume Share, by Type (2017-2028)

    • Table Global Hereditary Cancer Testing Sales Value, by Type (2017-2028)

    • Table Global Hereditary Cancer Testing Sales Value Share, by Type (2017-2028)

    • Figure Global Hereditary Cancer Testing Price Trend, by Type (2017-2028)

    • Table China Hereditary Cancer Testing Sales Volume, by Type (2017-2028)

    • Table China Hereditary Cancer Testing Sales Volume Share, by Type (2017-2028)

    • Figure China Hereditary Cancer Testing Sales Volume Share, by Type (2017-2028)

    • Table China Hereditary Cancer Testing Sales Value, by Type (2017-2028)

    • Table China Hereditary Cancer Testing Sales Value Share, by Type (2017-2028)

    • Figure China Hereditary Cancer Testing Price Trend, by Type (2017-2028)

    • Table Global Hereditary Cancer Testing Sales Volume, by Application (2017-2028)

    • Table Global Hereditary Cancer Testing Sales Volume Share, by Application (2017-2028)

    • Figure Global Hereditary Cancer Testing Sales Volume Share, by Application (2017-2028)

    • Table Global Hereditary Cancer Testing Sales Value, by Application (2017-2028)

    • Table Global Hereditary Cancer Testing Sales Value Share, by Application (2017-2028)

    • Figure Global Hereditary Cancer Testing Sales Value Share, by Application (2017-2028)

    • Table China Hereditary Cancer Testing Sales Volume, by Application (2017-2028)

    • Table China Hereditary Cancer Testing Sales Volume Share, by Application (2017-2028)

    • Figure China Hereditary Cancer Testing Sales Volume Share, by Application (2017-2028)

    • Table China Hereditary Cancer Testing Sales Value, by Application (2017-2028)

    • Table China Hereditary Cancer Testing Sales Value Share, by Application (2017-2028)

    • Figure China Hereditary Cancer Testing Sales Value Share, by Application (2017-2028)

    • Figure China Hereditary Cancer Testing Production, Import, Consumption and Export (2017-2022)

    • Figure North America Hereditary Cancer Testing Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Hereditary Cancer Testing Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Hereditary Cancer Testing Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Hereditary Cancer Testing Production, Import, Consumption and Export (2017-2022)

    • Table North America Hereditary Cancer Testing Sales Volume, by Type (2017-2028)

    • Table North America Hereditary Cancer Testing Sales Volume Share, by Type (2017-2028)

    • Figure North America Hereditary Cancer Testing Sales Volume Share, by Type (2017-2028)

    • Table North America Hereditary Cancer Testing Sales Volume, by Application (2017-2028)

    • Table North America Hereditary Cancer Testing Sales Volume Share, by Application (2017-2028)

    • Figure North America Hereditary Cancer Testing Sales Volume Share, by Application (2017-2028)

    • Figure United States Hereditary Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure United States Hereditary Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure Canada Hereditary Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Hereditary Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Hereditary Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Hereditary Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Table Europe Hereditary Cancer Testing Sales Volume, by Type (2017-2028)

    • Table Europe Hereditary Cancer Testing Sales Volume Share, by Type (2017-2028)

    • Figure Europe Hereditary Cancer Testing Sales Volume Share, by Type (2017-2028)

    • Table Europe Hereditary Cancer Testing Sales Volume, by Application (2017-2028)

    • Table Europe Hereditary Cancer Testing Sales Volume Share, by Application (2017-2028)

    • Figure Europe Hereditary Cancer Testing Sales Volume Share, by Application (2017-2028)

    • Figure Germany Hereditary Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Hereditary Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure UK Hereditary Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure UK Hereditary Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure France Hereditary Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure France Hereditary Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure Italy Hereditary Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Hereditary Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Hereditary Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Hereditary Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure Spain Hereditary Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Hereditary Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Hereditary Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Hereditary Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure Poland Hereditary Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Hereditary Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure Russia Hereditary Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Hereditary Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Hereditary Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Hereditary Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Table APAC Hereditary Cancer Testing Sales Volume, by Type (2017-2028)

    • Table APAC Hereditary Cancer Testing Sales Volume Share, by Type (2017-2028)

    • Figure APAC Hereditary Cancer Testing Sales Volume Share, by Type (2017-2028)

    • Table APAC Hereditary Cancer Testing Sales Volume, by Application (2017-2028)

    • Table APAC Hereditary Cancer Testing Sales Volume Share, by Application (2017-2028)

    • Figure APAC Hereditary Cancer Testing Sales Volume Share, by Application (2017-2028)

    • Figure China Hereditary Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure China Hereditary Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure Japan Hereditary Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Hereditary Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Hereditary Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Hereditary Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure India Hereditary Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure India Hereditary Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Hereditary Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Hereditary Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Hereditary Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Hereditary Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Hereditary Cancer Testing Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Hereditary Cancer Testing Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Hereditary Cancer Testing Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Hereditary Cancer Testing Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Hereditary Cancer Testing Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Hereditary Cancer Testing Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Hereditary Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Hereditary Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Hereditary Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Hereditary Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Hereditary Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Hereditary Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Hereditary Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Hereditary Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Hereditary Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Hereditary Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Table Laboratory Corporation of America Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Laboratory Corporation of America Product Profiles, Application and Specification

    • Table Laboratory Corporation of America Hereditary Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Myogenes Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Myogenes Product Profiles, Application and Specification

    • Table Myogenes Hereditary Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Biocartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Biocartis Product Profiles, Application and Specification

    • Table Biocartis Hereditary Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Myriad Genetics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Myriad Genetics Product Profiles, Application and Specification

    • Table Myriad Genetics Hereditary Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Quest Diagnostics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Quest Diagnostics Product Profiles, Application and Specification

    • Table Quest Diagnostics Hereditary Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pathway Genomics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pathway Genomics Product Profiles, Application and Specification

    • Table Pathway Genomics Hereditary Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Strand Life Sciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Strand Life Sciences Product Profiles, Application and Specification

    • Table Strand Life Sciences Hereditary Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Invitae Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Invitae Corporation Product Profiles, Application and Specification

    • Table Invitae Corporation Hereditary Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.